Peptech Limited (PTD) and Agenix Limited (AGX) are in talks for...

Peptech Limited (PTD) and Agenix Limited (AGX) are in talks for a A$450 million ($325 million) merger that may be announced as soon as today, the Australian Financial Review reported on its Web site. Peptech, which owns patents for antibodies used for arthritis drugs, plans to offer nine of its shares for every 11 Agenix shares, the newspaper reported, without saying where it got the information. The offer will value Agenix at more than A$200 million, it said. Peptech's market value is A$256 million. (Bloomberg)